A GREAT TIME FOR NEW INNOVATIONS

Monday, March 10, 2025

2:00 PM - 2:40 PM ET

Moderator(s)

Jonathan Schwartz, MD

Enterprise Director of Cardiovascular Innovation, Structural Interventional Cardiologist
Sanger Heart & Vascular Institute, North Carolina, United States

No relationships to disclose
Valavanur A. Subramanian, MD

Founder and Director Of Board
HRT- Heart Repair Technologies Inc.
New York, New York, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Jonathan Schwartz, MD: Abbott Vascular: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Cordis: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); CorFlow Therapeutics: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Lifelens LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); RapidAI: Consultant (Ongoing); Siemens: Consultant (Ongoing); W.L. Gore & Associates: Consultant (Ongoing)

Valavanur A. Subramanian, MD: No financial relationships to disclose